These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1403 related articles for article (PubMed ID: 32284348)

  • 1. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway.
    Baird L; Yamamoto M
    Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2.
    McMahon M; Swift SR; Hayes JD
    Toxicol Appl Pharmacol; 2018 Dec; 360():45-57. PubMed ID: 30261176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keap1 degradation by autophagy for the maintenance of redox homeostasis.
    Taguchi K; Fujikawa N; Komatsu M; Ishii T; Unno M; Akaike T; Motohashi H; Yamamoto M
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13561-6. PubMed ID: 22872865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
    Villeneuve NF; Lau A; Zhang DD
    Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sp1 is a substrate of Keap1 and regulates the activity of CRL4A
    Siswanto FM; Oguro A; Imaoka S
    J Biol Chem; 2021; 296():100704. PubMed ID: 33895141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Basis of the KEAP1-NRF2 Signaling Pathway.
    Suzuki T; Takahashi J; Yamamoto M
    Mol Cells; 2023 Mar; 46(3):133-141. PubMed ID: 36994473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.
    Kobayashi A; Kang MI; Okawa H; Ohtsuji M; Zenke Y; Chiba T; Igarashi K; Yamamoto M
    Mol Cell Biol; 2004 Aug; 24(16):7130-9. PubMed ID: 15282312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
    Suzuki T; Yamamoto M
    J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical and non-canonical mechanisms of Nrf2 activation.
    Silva-Islas CA; Maldonado PD
    Pharmacol Res; 2018 Aug; 134():92-99. PubMed ID: 29913224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
    Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
    Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.
    Lau A; Wang XJ; Zhao F; Villeneuve NF; Wu T; Jiang T; Sun Z; White E; Zhang DD
    Mol Cell Biol; 2010 Jul; 30(13):3275-85. PubMed ID: 20421418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.
    Zhang DD; Lo SC; Sun Z; Habib GM; Lieberman MW; Hannink M
    J Biol Chem; 2005 Aug; 280(34):30091-9. PubMed ID: 15983046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of KEAP1/NRF2 stress signaling involved in the molecular basis of hemin-induced cytotoxicity in human pro-erythroid K562 cells.
    Georgiou-Siafis SK; Tsiftsoglou AS
    Biochem Pharmacol; 2020 May; 175():113900. PubMed ID: 32156661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease.
    Dayalan Naidu S; Dinkova-Kostova AT
    Open Biol; 2020 Jun; 10(6):200105. PubMed ID: 32574549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an adaptor protein that facilitates Nrf2-Keap1 complex formation and modulates antioxidant response.
    Zhang Y; Hou Y; Liu C; Li Y; Guo W; Wu JL; Xu D; You X; Pan Y; Chen Y
    Free Radic Biol Med; 2016 Aug; 97():38-49. PubMed ID: 27212020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.